NO991382D0 - Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin - Google Patents

Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin

Info

Publication number
NO991382D0
NO991382D0 NO991382A NO991382A NO991382D0 NO 991382 D0 NO991382 D0 NO 991382D0 NO 991382 A NO991382 A NO 991382A NO 991382 A NO991382 A NO 991382A NO 991382 D0 NO991382 D0 NO 991382D0
Authority
NO
Norway
Prior art keywords
olanzapine
intermediates
preparation
Prior art date
Application number
NO991382A
Other languages
English (en)
Other versions
NO323980B1 (no
NO991382L (no
Inventor
Charles A Bunnell
Samuel D Larsen
John R Nichols
Susan M Reutzel
Gregory A Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991382(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991382D0 publication Critical patent/NO991382D0/no
Publication of NO991382L publication Critical patent/NO991382L/no
Publication of NO323980B1 publication Critical patent/NO323980B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
NO19991382A 1996-09-23 1999-03-22 Krystallinsk dihydrat B eller E olanzapin, fremgangsmate for fremstilling av Form II olanzapin samt preparat NO323980B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23
PCT/US1997/016499 WO1998012199A1 (en) 1996-09-23 1997-09-18 Intermediates and process for preparing olanzapine

Publications (3)

Publication Number Publication Date
NO991382D0 true NO991382D0 (no) 1999-03-22
NO991382L NO991382L (no) 1999-03-22
NO323980B1 NO323980B1 (no) 2007-07-30

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991382A NO323980B1 (no) 1996-09-23 1999-03-22 Krystallinsk dihydrat B eller E olanzapin, fremgangsmate for fremstilling av Form II olanzapin samt preparat

Country Status (36)

Country Link
US (1) US6020487A (no)
EP (1) EP0831098B1 (no)
JP (2) JP2001500877A (no)
KR (1) KR100560015B1 (no)
CN (1) CN1122036C (no)
AR (1) AR013838A1 (no)
AT (1) ATE209208T1 (no)
AU (1) AU719441B2 (no)
BR (1) BR9712100A (no)
CA (1) CA2265712C (no)
CO (1) CO4910140A1 (no)
CZ (1) CZ299248B6 (no)
DE (1) DE69708428T2 (no)
DK (1) DK0831098T3 (no)
EA (1) EA001642B1 (no)
EG (1) EG23861A (no)
ES (1) ES2166051T3 (no)
HK (1) HK1009807A1 (no)
HU (1) HU226484B1 (no)
ID (1) ID27275A (no)
IL (1) IL128962A (no)
IN (1) IN187156B (no)
MY (1) MY125565A (no)
NO (1) NO323980B1 (no)
NZ (1) NZ334448A (no)
PE (1) PE110398A1 (no)
PL (3) PL196068B1 (no)
PT (1) PT831098E (no)
RS (1) RS49598B (no)
SI (1) SI0831098T1 (no)
SV (1) SV1997000081A (no)
TR (1) TR199900640T2 (no)
TW (1) TW470746B (no)
UA (1) UA59371C2 (no)
WO (1) WO1998012199A1 (no)
ZA (1) ZA978515B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003566A3 (cs) * 2000-08-31 2004-01-14 Dr. Reddy's Laboratories Ltd. Způsob přípravy hydrátů olanzapinu a jejich konverze na krystalické formy olanzapinu
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
CA2464306A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CH695862A5 (fr) 2001-12-24 2006-09-29 Sun Pharmaceutical Ind Ltd Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
SI1513846T1 (sl) 2002-05-31 2011-11-30 Sandoz Ag Postopek za pripravo olanzapina form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
CA2546200A1 (en) * 2003-11-18 2005-06-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
CA2551806A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries, Ltd. Methods of preparing olanzapine
DE602005027308D1 (de) 2004-01-27 2011-05-19 Synthon Bv Stabile salze von olanzapin
WO2005080401A1 (en) * 2004-02-19 2005-09-01 Neuland Laboratories Limited Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
EP2623095A1 (en) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
ES2153373T3 (es) * 1992-05-29 2001-03-01 Lilly Co Eli Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central.
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
ID21924A (id) * 1996-09-23 1999-08-12 Lilly Co Eli Olanzapin dihidrat d

Also Published As

Publication number Publication date
ID27275A (id) 2001-03-22
IL128962A0 (en) 2000-02-17
YU15599A (sh) 2001-12-26
AU4484197A (en) 1998-04-14
JP2001500877A (ja) 2001-01-23
TW470746B (en) 2002-01-01
EA001642B1 (ru) 2001-06-25
ZA978515B (en) 1999-03-23
NO323980B1 (no) 2007-07-30
SI0831098T1 (en) 2002-04-30
DK0831098T3 (da) 2002-05-21
KR20000048520A (ko) 2000-07-25
EP0831098A2 (en) 1998-03-25
PL196068B1 (pl) 2007-12-31
CZ299248B6 (cs) 2008-05-28
ES2166051T3 (es) 2002-04-01
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
CA2265712A1 (en) 1998-03-26
HUP0000066A2 (hu) 2000-06-28
CZ99099A3 (cs) 1999-11-17
PT831098E (pt) 2002-04-29
AR013838A1 (es) 2001-01-31
JP2009242407A (ja) 2009-10-22
PE110398A1 (es) 1999-01-14
DE69708428D1 (de) 2002-01-03
TR199900640T2 (xx) 1999-06-21
NO991382L (no) 1999-03-22
KR100560015B1 (ko) 2006-03-15
HK1009807A1 (en) 1999-06-11
DE69708428T2 (de) 2002-07-04
CN1234802A (zh) 1999-11-10
HU226484B1 (en) 2009-03-02
BR9712100A (pt) 1999-08-31
AU719441B2 (en) 2000-05-11
CN1122036C (zh) 2003-09-24
CO4910140A1 (es) 2000-04-24
SV1997000081A (es) 1999-01-14
CA2265712C (en) 2006-10-31
US6020487A (en) 2000-02-01
RS49598B (sr) 2007-06-04
HUP0000066A3 (en) 2000-11-28
IL128962A (en) 2003-01-12
EP0831098B1 (en) 2001-11-21
PL194565B1 (pl) 2007-06-29
IN187156B (no) 2002-02-16
EP0831098A3 (en) 1998-04-29
PL196069B1 (pl) 2007-12-31
ATE209208T1 (de) 2001-12-15
PL332482A1 (en) 1999-09-13
EG23861A (en) 2007-11-18
EA199900326A1 (ru) 1999-08-26
UA59371C2 (uk) 2003-09-15
MY125565A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
NO990432D0 (no) FremgangsmÕte for fremstilling av aminer og aminonitriler
PT829205E (pt) Producao de condimento
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
NO994505D0 (no) Forbedret fremgangsmÕte for fremstilling av tiazolidindioner og nye tiazolidindioner
EE03438B1 (et) Felodipiini valmistamise protsess
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
NO20002873L (no) FremgangsmÕte for økning av produksjonen og forbedring av kvaliteten til sæd
ID18300A (id) Metoda penemperan
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
NO990018D0 (no) Belegg og fremgangsmÕte for fremstilling derav
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
EE200100333A (et) Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine
EE200000357A (et) Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid
DK0747365T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af
NO961871L (no) Apparat og fremgangsmåte for fremstilling av flerforpakninger
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
DK0983999T3 (da) Fremgangsmåde til fremstilling af amidderivater og mellemprodukter

Legal Events

Date Code Title Description
MK1K Patent expired